Download Files:
KH-CB20
SKU
HY-12828A-1 mg
Category Reference compound
Tags CDK;DYRK, Cell Cycle/DNA Damage;Protein Tyrosine Kinase/RTK, Infection; Neurological Disease
$180 – $890
Products Details
Product Description
– KH-CB20, an E/Z mixture, is a potent and selective inhibitor of CLK1 and the closely related isoform CLK4, with an IC50 of 16.5 nM for CLK1. KH-CB20 can also inhibit DYRK1A (IC50=57.8 nM) and CLK3 (IC50=488 nM)[1].
Web ID
– HY-12828A
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C15H13Cl2N3O2
References
– [1]Fedorov O, et, al. Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing. Chem Biol. 2011 Jan 28;18(1):67-76.
CAS Number
– 1354448-60-4
Molecular Weight
– 338.19
Compound Purity
– 99.80
SMILES
– CCOC(C1=C(C2=C(C(Cl)=C(C=C2)Cl)N1C)/C(C#N)=CN)=O
Clinical Information
– No Development Reported
Research Area
– Infection; Neurological Disease
Solubility
– DMSO : 100 mg/mL (ultrasonic;warming)
Target
– CDK;DYRK
Isoform
– CLK;DYRK1
Pathway
– Cell Cycle/DNA Damage;Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.